Evaluation of SARS-CoV-2 total antibody detection via a lateral flow nanoparticle fluorescence immunoassay
- 1 April 2021
- journal article
- research article
- Published by Elsevier BV in Journal of Clinical Virology
- Vol. 139, 104818
- https://doi.org/10.1016/j.jcv.2021.104818
Abstract
No abstract availableFunding Information
- National Institute of Allergy and Infectious Diseases (1U54CA260517, R01AI130398, R01AI127877)
- Cronk Family Foundation (1U54CA260517, R01AI130398, R01AI127877)
- National Institutes of Health (1U54CA260517, R01AI130398, R01AI127877)
This publication has 25 references indexed in Scilit:
- Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patientsClinical Microbiology & Infection, 2020
- The Role of Antibody Testing for SARS-CoV-2: Is There One?Journal of Clinical Microbiology, 2020
- Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisationJournal of Clinical Virology, 2020
- Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech)Journal of Clinical Virology, 2020
- Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Assays in Different Stages of Infection: Comparison of Commercial Enzyme-Linked Immunosorbent Assays and Rapid TestsThe Journal of Infectious Diseases, 2020
- Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodiesJournal of Clinical Virology, 2020
- Antibody responses to SARS-CoV-2 in patients with COVID-19Nature Medicine, 2020
- Nanowire-Based Biosensors: From Growth to ApplicationsMicromachines, 2018
- Commensal–Pathogen Interactions along the Human Nasal PassagesPLoS Pathogens, 2016
- The Measurement of Observer Agreement for Categorical DataBiometrics, 1977